IVME Financial Statements From 2010 to 2026
| IVMEDelisted Stock | USD 0.0007 0.00 0.00% |
Check In Veritas financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among In Veritas' main balance sheet or income statement drivers, such as , as well as many indicators such as . IVME financial statements analysis is a perfect complement when working with In Veritas Valuation or Volatility modules.
IVME |
In Veritas Medical Company Shares Outstanding Analysis
In Veritas' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current In Veritas Shares Outstanding | 86.05 M |
Most of In Veritas' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, In Veritas Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, In Veritas Medical has 86.05 M of shares currently outstending. This is 95.31% lower than that of the Capital Markets sector and significantly higher than that of the Financials industry. The shares outstanding for all United States stocks is 84.95% higher than that of the company.
In Veritas Medical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining In Veritas's current stock value. Our valuation model uses many indicators to compare In Veritas value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across In Veritas competition to find correlations between indicators driving In Veritas's intrinsic value. More Info.In Veritas Medical is rated second overall in return on asset category among its peers. It is considered the number one company in current valuation category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value In Veritas by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About In Veritas Financial Statements
In Veritas stakeholders use historical fundamental indicators, such as In Veritas' revenue or net income, to determine how well the company is positioned to perform in the future. Although In Veritas investors may analyze each financial statement separately, they are all interrelated. For example, changes in In Veritas' assets and liabilities are reflected in the revenues and expenses on In Veritas' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in In Veritas Medical. Please read more on our technical analysis and fundamental analysis pages.
In Veritas Medical Diagnostics, Inc., a development stage company, engages in the research and development of medical devices with near-patient testing applications. It was formerly known as In Vivo Medical Diagnostics, Inc. and changed its name to In Veritas Medical Diagnostics, Inc. in 2005. IN Veritas operates under Shell Companies classification in the United States and is traded on OTC Exchange. It employs 7 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in IVME Stock
If you are still planning to invest in In Veritas Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the In Veritas' history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |